Dr. Kieran Harkin:

It is not our area of expertise but the agreement the State had with the pharmaceutical industry was that savings from generics would be for prescribing drugs. My understanding, however, is that all of that budget has been used up and, therefore, that almost all the savings due for new drugs have been used by the end of February. In previous years, when it was decided to approve and reimburse Orkambi, that took up a substantial sum of the moneys that had been pencilled in to be used for new drugs.